Claritev (CTEV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Claritev (CTEV) is Neutral.

The composite score behind that read is -0.03, weighing +0.71 of bullish evidence against -0.29 bearish.

Claritev last closed at $24.66, +1.36% on the session.

Against the IVW growth benchmark the position is +0.56% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

15 graded predictions for CTEV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Claritev in the 97th percentile on return on equity, where 100 is best.

Claritev is classified under Health Care / Health Care Technology, with a market capitalisation of $412.32M.

StockMap tracks Claritev as the 13th largest of the 20 companies it covers in the Health Care Technology industry, part of the Health Care sector.

Across that group the current two-week reads are 14 Neutral, 5 Moderate Underperform and 1 Moderate Outperform.

On that composite Claritev ranks 12th of 20 in the group, against a group median of +0.01.